부산대학교 도서관

Perez KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Horick N; Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts.; Baginksa J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Giobbie-Hurder A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Gomez Diaz I; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Nau AN; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Dryg ID; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Pfaff K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Rodig SJ; Harvard Medical School, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Redston M; Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Bird A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Hovalanska M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Abrams T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Patel A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Schlechter BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Kulke MH; Section of Hematology and Oncology, Boston University and Boston Medical Center, Boston, Massachusetts.; Chan JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Singh H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. harshabad_singh@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. harshabad_singh@dfci.harvard.edu.; Lowder KE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Kapner K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Kelly RJ; Johns Hopkins Hospital & School of Medicine, Baltimore, MD, USA.; Charles A. Sammons Cancer Center at Baylor University Medical Center, Dallas, TX, USA.; Zheng H; Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital, Boston, MA, USA.; McCleary NJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Abrams TA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Chan JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Regan EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Klempner SJ; Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital, Boston, MA, USA.; Hannigan AM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Remland J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Brais LK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Andrews E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Yurgelun M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Ritterhouse LL; Harvard Medical School, Boston, MA, USA.; Center for Integrated Diagnostics, Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.; Maron G; Center for Integrated Diagnostics, Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.; Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; The Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Meyerhardt JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Gardecki E; Harvard Medical School, Boston, MA, USA.; Center for Integrated Diagnostics, Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.; Lennerz JK; Harvard Medical School, Boston, MA, USA.; Center for Integrated Diagnostics, Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.; Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Enzinger PC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. peter_enzinger@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. peter_enzinger@dfci.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Surana R; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Morgado M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Somasundaram A; Division of Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Bockorny B; Department of Medical Oncology, Beth Israel Deaconess Hospital and Harvard Medical School, Boston, MA.; Weekes CD; Department of Medical Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.; Coleman EC; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Bird A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Wang J; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Williams HL; Department of Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Zheng H; Biostatistics Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA.; Brais LK; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Saxena N; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Graham C; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Ritterband L; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Sawin M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Peters ML; Department of Medical Oncology, Beth Israel Deaconess Hospital and Harvard Medical School, Boston, MA.; Whooley P; Department of Medical Oncology, Beth Israel Deaconess Hospital and Harvard Medical School, Boston, MA.; Bullock A; Department of Medical Oncology, Beth Israel Deaconess Hospital and Harvard Medical School, Boston, MA.; Zerillo J; Department of Medical Oncology, Beth Israel Deaconess Hospital and Harvard Medical School, Boston, MA.; Sanoff HK; Division of Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Clark JW; Department of Medical Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.; Parikh AR; Department of Medical Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA.; Yurgelun MB; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Patel AK; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Mayer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Enzinger P; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; McCleary NJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Enzinger A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Slater S; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Biller LH; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Abrams TA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Huffman BM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Singh H; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Raghavan S; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Mancias JD; Department of Radiation Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Bryant KL; Department of Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Nowak JO; Department of Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.; Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Der CJ; Department of Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.; Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.; Perez K; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

Lipsyc-Sharf, Marla; Ou, Fang-Shu; Yurgelun, Matthew B; Rubinson, Douglas A; Schrag, Deborah; Dakhil, Shaker R; Stella, Philip J; Weckstein, Douglas J; Wender, Donald B; Faggen, Meredith; Zemla, Tyler J; Heying, Erica N; Schuetz, Samantha R; Noble, Stephanie; Meyerhardt, Jeffrey A; Bekaii-Saab, Tanios; Fuchs, Charles S; Ng, Kimmie

Oncologist; Apr2022, Vol. 27 Issue 4, p292-298, 7p, 1 Diagram, 2 Charts, 1 Graph

Mayers, Jared R; Wu, Chen; Clish, Clary B; Kraft, Peter; Torrence, Margaret E; Fiske, Brian P; Yuan, Chen; Bao, Ying; Townsend, Mary K; Tworoger, Shelley S; Davidson, Shawn M; Papagiannakopoulos, Thales; Yang, Annan; Dayton, Talya L; Ogino, Shuji; Stampfer, Meir J; Giovannucci, Edward L; Qian, Zhi Rong; Rubinson, Douglas A; Ma, Jing

Nature Medicine. Oct2014, Vol. 20 Issue 10, p1193-1198. 6p. 1 Chart, 3 Graphs.

Yu L; Dana-Farber Cancer Institute, Boston, MA.; Espiritu J; Dana-Farber Cancer Institute, Boston, MA.; Patel K; Channing Division of Network Medicine, Department of Medicine, Harvard Medical School, Boston, MA.; Rosner BA; Channing Division of Network Medicine, Department of Medicine, Harvard Medical School, Boston, MA.; Rompelman GH; Dana-Farber Cancer Institute, Boston, MA.; Rubinson DA; Dana-Farber Cancer Institute, Boston, MA.; Jacobson JO; Dana-Farber Cancer Institute, Boston, MA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE

Barzi A; AccessHope, Duarte, CA 91010, USA.; Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA 91010, USA.; Kim AJ; AccessHope, Duarte, CA 91010, USA.; Liang CK; AccessHope, Duarte, CA 91010, USA.; West H; AccessHope, Duarte, CA 91010, USA.; Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA 91010, USA.; Wong D; AccessHope, Duarte, CA 91010, USA.; Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA 91010, USA.; Wright C; AccessHope, Duarte, CA 91010, USA.; Nathwani N; Department of Hematology and Hematopoietic Stem Cell Transplant, City of Hope, Duarte, CA 91011, USA.; Vasko CM; AccessHope, Duarte, CA 91010, USA.; Chung V; Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA 91010, USA.; Rubinson DA; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA.; Sachs T; AccessHope, Duarte, CA 91010, USA.

Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101602269 Publication Model: Electronic Cited Medium: Print ISSN: 2075-4426 (Print) Linking ISSN: 20754426 NLM ISO Abbreviation: J Pers Med Subsets: PubMed not MEDLINE

Huffman BM; Dana-Farber Cancer Institute Boston, MA United States.; Diossy M; Danish Cancer Society Research Center Copenhagen Denmark.; Yurgelun MB; Dana-Farber/Brigham and Women's Cancer Center Boston United States.; Horick N; Massachusetts General Hospital Boston, MA United States.; Li YY; Dana-Farber Cancer Institute Boston, MA United States.; Crowdis J; Harvard University United States.; Nguyen H; Dana-Farber Cancer Institute Boston, MA United States.; Parmar K; Dana-Farber Cancer Institute Boston, Massachusetts United States.; Kochupurakkal BS; Dana-Farber/Harvard Cancer Center Boston, MA United States.; Vonk L; Dana-Farber/Brigham and Women's Cancer Center Boston United States.; Lam H; Dana-Farber Cancer Institute Boston, Massachusetts United States.; Ramsey K; Dana-Farber Cancer Institute United States.; Andrews E; Dana-Farber Cancer Institute Boston, MA United States.; Loeb SC; Dana-Farber Cancer Institute United States.; Culnane L; Dana-Farber Cancer Institute United States.; Biller LH; Dana-Farber/Brigham and Women's Cancer Center Boston United States.; Bullock AJ; Beth Israel Deaconess Medical Center, Harvard Medical School Boston United States.; Enzinger A; Dana-Farber Cancer Institute United States.; Giannakis M; Dana-Farber Cancer Institute Boston, MA United States.; Jackson NA; Dana-Farber Cancer Institute Boston, MA United States.; Ng K; Dana-Farber Cancer Institute Boston, MA United States.; Nowak JA; Brigham and Women's Hospital Boston, MA United States.; Patel AK; Dana-Farber Cancer Institute Boston, MA United States.; Perez KJ; Dana-Farber Cancer Institute Boston, MA United States.; Rattani A; Beth Israel Deaconess Medical Center United States.; Rubinson DA; Dana-Farber Cancer Institute Boston, MA United States.; Schlechter BL; Dana-Farber Cancer Institute Boston, MA United States.; Singh H; Dana-Farber Cancer Institute Boston, MA United States.; Cai M; Guardant Health Palo Alto, CA United States.; Raghavan S; Dana-Farber Cancer Institute Boston, Massachusetts United States.; Clark JW; Massachusetts General Hospital Boston, MA United States.; Peters ML; Beth Israel Deaconess Medical Center Boston, MA United States.; Weipert CM; Guardant Health, Inc. Redwood City, CA United States.; Wolpin BM; Dana-Farber Cancer Institute Boston, MA United States.; D'Andrea AD; Dana-Farber Cancer Institute Boston, MA United States.; Shapiro GI; Dana-Farber Cancer Institute Boston, MA United States.; Aguirre AJ; Dana-Farber Cancer Institute Boston, MA United States.; Szallasi Z; Harvard University Boston, MA United States.; Cleary JM; Dana-Farber Cancer Institute Boston, MA United States.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Oberstein PE; Department of Medicine, NYU Langone Health, New York, New York.; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Dias Costa A; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Kawaler EA; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Department of Surgery, NYU Langone Health, New York, New York.; Cardot-Ruffino V; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Rahma OE; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Beri N; Department of Medicine, NYU Langone Health, New York, New York.; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Singh H; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Abrams TA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Biller LH; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Enzinger P; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Huffman BM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; McCleary NJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Perez KJ; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Schlechter BL; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Surana R; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Yurgelun MB; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Wang SJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Remland J; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Brais LK; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Bollenrucher N; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Chang E; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ali LR; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Lenehan PJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.; Dolgalev I; Department of Medicine, NYU Langone Health, New York, New York.; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Werba G; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Department of Surgery, NYU Langone Health, New York, New York.; Lima C; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Keheler CE; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Sullivan KM; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Dougan M; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Hajdu C; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Department of Pathology, NYU Langone Health, New York, New York.; Dajee M; Novartis Institute for Biomedical Research, Cambridge, Massachusetts.; Pelletier MR; Novartis Institute for Biomedical Research, Cambridge, Massachusetts.; Nazeer S; Novartis Pharmaceuticals, Cambridge, Massachusetts.; Squires M; Novartis Pharmaceuticals, Cambridge, Massachusetts.; Bar-Sagi D; Department of Medicine, NYU Langone Health, New York, New York.; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Nowak JA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Simeone DM; Perlmutter Cancer Center, NYU Langone Health, New York, New York.; Department of Surgery, NYU Langone Health, New York, New York.; Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Immunology, Harvard Medical School, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

DeRidder LB; Harvard-MIT Division of Health Science Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Hare KA; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Lopes A; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Jenkins J; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Fitzgerald N; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; MacPherson E; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Fabian N; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Morimoto J; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Chu JN; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Harvard Medical School, Boston, MA 02115, USA; Division of Gastroenterology, Massachusetts General Hospital, Boston, MA 02114, USA.; Kirtane AR; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Madani W; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Ishida K; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Kuosmanen JLP; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Zecharias N; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Colangelo CM; Agilent Technologies, Lexington, MA 02421, USA.; Huang HW; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Chilekwa M; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Lal NB; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; MIT Media Lab, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Srinivasan SS; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Hayward AM; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Wolpin BM; Harvard Medical School, Boston, MA 02115, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.; Trumper D; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Quast T; College of Public Health, University of South Florida, Tampa, FL 33612, USA.; Rubinson DA; Harvard Medical School, Boston, MA 02115, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.; Langer R; Harvard-MIT Division of Health Science Technology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Traverso G; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Division of Gastroenterology, Hepatology, and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Electronic address: cgt20@mit.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 101769215 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6340 (Electronic) Linking ISSN: 26666340 NLM ISO Abbreviation: Med Subsets: MEDLINE

Morales-Oyarvide, Vicente; Rubinson, Douglas A; Dunne, Richard F; Kozak, Margaret M; Bui, Justin L; Yuan, Chen; Qian, Zhi Rong; Babic, Ana; Da Silva, Annacarolina; Nowak, Jonathan A; Khalaf, Natalia; Brais, Lauren K; Welch, Marisa W; Zellers, Caitlin L; Ng, Kimmie; Chang, Daniel T; Miksad, Rebecca A; Bullock, Andrea J; Tseng, Jennifer F; Swanson, Richard S

British Journal of Cancer. 12/5/2017, Vol. 117 Issue 12, p1874-1882. 9p. 5 Charts, 1 Graph.

Rubinson DA; Dana Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Tanaka N; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Fece de la Cruz F; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Kapner KS; Dana Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Rosenthal MH; Dana Farber Cancer Institute and Brigham and Women's Hospital, Department of Radiology, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Norden BL; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Barnes H; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Ehnstrom S; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Morales-Giron AA; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Brais LK; Dana Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; Lemke CT; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Aguirre AJ; Dana Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Corcoran RB; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Singh H; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Sahgal P; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Kapner K; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Corsello SM; Department of Medicine, Stanford University, Palo Alto, California.; Gupta H; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Gujrathi R; Department of Radiology, Boston Medical Center and Boston University, Boston, Massachusetts.; Li YY; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Cherniack AD; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; El Alam R; Department of Radiology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Kerfoot J; Department of Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Andrews E; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Lee A; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Nambiar C; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Hannigan AM; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Remland J; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Brais L; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Leahy ME; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Rubinson DA; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Schlechter BL; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Meyerson M; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Department of Genetics, Harvard Medical School, Boston, Massachusetts.; Kuang Y; Belfer Center for Applied Cancer Science, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Paweletz CP; Belfer Center for Applied Cancer Science, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lee JK; Foundation Medicine, Inc., Cambridge, Massachusetts.; Quintanilha JCF; Foundation Medicine, Inc., Cambridge, Massachusetts.; Aguirre AJ; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Perez KJ; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Huffman BM; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Rossi H; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Abrams TA; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Kabraji S; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Trusolino L; Candiolo Cancer Institute FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy.; Bertotti A; Candiolo Cancer Institute FPO IRCCS, Candiolo, Torino, Italy.; Department of Oncology, University of Torino, Candiolo, Torino, Italy.; Sicinska ET; Department of Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Parikh AR; Massachusetts General Hospital Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.; Wolpin BM; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Schrock AB; Foundation Medicine, Inc., Cambridge, Massachusetts.; Giannakis M; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Ng K; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Meyerhardt JA; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Hornick JL; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Sethi NS; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Cleary JM; Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Khayat-Khoei M; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Conway S; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Jarolim P; Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA, USA.; Houtchens MK; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. mhoutchens@bwh.harvard.edu.

Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1459 (Electronic) Linking ISSN: 03405354 NLM ISO Abbreviation: J Neurol Subsets: MEDLINE

Ben-Ami R; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.; Wang QL; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.; Zhang J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Supplee JG; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Fahrmann JF; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Lehmann-Werman R; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.; Brais LK; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Nowak J; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Yuan C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Loftus M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Babic A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Irajizad E; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Davidi T; Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.; Zick A; Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.; Hubert A; Sharett Institute of Oncology, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.; Neiman D; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.; Piyanzin S; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.; Gal-Rosenberg O; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.; Horn A; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.; Shemer R; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.; Glaser B; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.; Department of Endocrinology and Metabolism, Hadassah Medical Center, Jerusalem, Israel.; Boos N; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Jajoo K; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Lee L; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Clancy TE; Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Chabot JA; Department of Surgery, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, USA.; Kastrinos F; Division of Digestive and Liver Diseases, Columbia University Irving Medical Cancer and the Vagelos College of Physicians and Surgeons, New York, New York, USA.; Kluger M; Department of Surgery, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, USA.; Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Jänne PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Bardeesy N; Massachusetts General Hospital Cancer Center, Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts, USA.; Stanger B; Department of Medicine, Division of Gastroenterology, Abramson Family Cancer Research Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.; O'Hara MH; Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Till J; Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Maitra A; Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.; Carpenter EL; Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Bullock AJ; Division of Hematology and Oncology, Beth-Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.; Genkinger J; Department of epidemiology, Mailman school of public health, Columbia university, New York, New York, USA.; Herbert Irving Comprehensive Cancer Center, Columbia university Irving Medical Center, New York, New York, USA.; Hanash SM; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Paweletz CP; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Dor Y; Department of Developmental Biology and Cancer Research, IMRIC, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel Brian_Wolpin@dfci.harvard.edu yuvald@ekmd.huji.ac.il.; Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA Brian_Wolpin@dfci.harvard.edu yuvald@ekmd.huji.ac.il.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Publisher: British Medical Assn Country of Publication: England NLM ID: 2985108R Publication Model: Electronic Cited Medium: Internet ISSN: 1468-3288 (Electronic) Linking ISSN: 00175749 NLM ISO Abbreviation: Gut Subsets: MEDLINE

Huffman BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Singh H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Ali LR; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Horick N; Massachusetts General Hospital, Boston, Massachusetts, USA.; Wang SJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Hoffman MT; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Metayer KA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Murray S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Bird A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Abrams TA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Biller LH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Chan JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Meyerhardt JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; McCleary NJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Goessling W; Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Patel AK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Wisch JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Yurgelun MB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Mouw K; Harvard Medical School, Boston, Massachusetts, USA.; Reardon B; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Zerillo JA; Harvard Medical School, Boston, Massachusetts, USA.; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.; Clark JW; Department of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Parikh A; Massachusetts General Hospital, Boston, Massachusetts, USA.; Mayer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Schlechter B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Kumar S; Naveris, Inc, Waltham, Massachusetts, USA.; Del Vecchio Fitz C; Naveris, Inc, Waltham, Massachusetts, USA.; Kuperwasser C; Naveris, Inc, Waltham, Massachusetts, USA.; Hanna GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Coveler AL; University of Washington School of Medicine, Seattle, Washington, USA.; Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Welsh EL; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Pfaff K; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Rodig S; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA James_Cleary@dfci.harvard.edu stephanie_dougan@dfci.harvard.edu srodig@bwh.harvard.edu.; Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA James_Cleary@dfci.harvard.edu stephanie_dougan@dfci.harvard.edu srodig@bwh.harvard.edu.; Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA James_Cleary@dfci.harvard.edu stephanie_dougan@dfci.harvard.edu srodig@bwh.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Huffman BM; Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.; Feng H; Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.; Parmar K; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Wang J; Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.; Kapner KS; Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.; Kochupurakkal B; Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, Massachusetts.; Martignetti DB; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Sadatrezaei G; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Abrams TA; Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.; Biller LH; Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.; Giannakis M; Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.; Patel AK; Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.; Perez KJ; Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.; Singh H; Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.; Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.; Schlechter BL; Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.; Andrews E; Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.; Hannigan AM; Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.; Dunwell S; Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.; Getchell Z; Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.; Raghavan S; Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.; Fortier C; Esperas Pharma, Montreal, Canada.; D'Andrea AD; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.; Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute/Harvard Medical School, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Singh H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Keller RB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Kapner KS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Dilly J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Biological and biomedical sciences program, Harvard Medical School, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Raghavan S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Yuan C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cohen EF; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Tolstorukov M; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Andrews E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Brais LK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; da Silva A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pathology, Weill Cornell Medical College, New York, New York.; Perez K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Surana R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Giannakis M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Clancy TE; Harvard Medical School, Boston, Massachusetts.; Division of Surgical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.; Yurgelun MB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Schlechter BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Clark JW; Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Shapiro GI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Rosenthal MH; Department of Radiology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts.; Hornick JL; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Nardi V; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts.; Li YY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Gupta H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Cherniack AD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Meyerson M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Nowak JA; Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Cardot-Ruffino V; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Immunology, Harvard Medical School, Boston, Massachusetts, USA.; Bollenrucher N; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Delius L; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Wang SJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Brais LK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Remland J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Keheler CE; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Sullivan KM; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Abrams TA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Biller LH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Enzinger PC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; McCleary NJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Patel AK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Schlechter B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Slater S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Yurgelun MB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Perez K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Dougan M; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Singh H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA stephanie_dougan@dfci.harvard.edu.; Department of Immunology, Harvard Medical School, Boston, Massachusetts, USA.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Singh H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Klempner SJ; Harvard Medical School, Boston, MA.; Massachusetts General Hospital Cancer Center, Boston, MA.; Melnitchouk N; Harvard Medical School, Boston, MA.; Department of Surgery, Brigham and Women's Hospital, Boston, MA.; Chander DP; Dana-Farber Cancer Institute at South Shore Hospital, Weymouth, MA.; Negrea OG; Memorial Health University Medical Center, Savannah, GA.; Patel AK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Schlechter BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Huffman BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Nambiar C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Remland J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Andrews E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Leahy ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Brais LK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Enzinger PC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Mamon HJ; Harvard Medical School, Boston, MA.; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA.; Giannakis M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Meyerhardt JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Perez KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Aguirre AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Clark JW; Harvard Medical School, Boston, MA.; Massachusetts General Hospital Cancer Center, Boston, MA.; Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE